Market Overview:
The global nebulizers market reached a value of US$ 1.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 1.9 Billion by 2027, exhibiting a CAGR of 7.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Nebulizers are devices that are used by patients suffering from respiratory diseases to administer the medication directly into the lungs. Usually made up of a motor, mouthpiece, cup and tubing, these devices turn liquid medicine into a fine mist by using oxygen, compressed air or ultrasonic power for breaking up the liquid drug into aerosols. They are prescribed by doctors to people who are unable to breathe deeply while using an inhaler. Nebulizers are primarily utilized for providing relief from extreme breathing conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, etc.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Rising prevalence of chronic respiratory diseases is a major factor boosting the growth of the market. Busy schedules, sedentary lifestyles and a lack of physical activities have led to an increase in prevalence of obesity across the globe. This, in confluence with escalating consumption of tobacco and alcohol, is significantly contributing to the increasing occurrence of respiratory disorders, thereby bolstering the sales of nebulizers. Apart from this, rising pollution levels on account of increasing adoption of private vehicles and expansion of industries is another key factor that is contributing to the product’s demand globally. Moreover, the growing geriatric population has led to an increase in the demand for home healthcare devices, which is driving the demand for portable variants. Furthermore, several organizations are taking initiatives to spread awareness about the available treatment options for respiratory diseases. For instance, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) is actively educating the public about the risks posed by COPD and the treatment of the same.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global nebulizers market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product type, portability, end-user and application.
Breakup by Product Type:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Pneumatic Nebulizers
- Ultrasonic Nebulizers
- Mesh Nebulizers
- Others
Breakup by Portability:
- Portable Nebulizers
- Standalone Nebulizers
Breakup by End-User:
- Hospitals and Clinics
- Long Term Healthcare Centers
- Homecare Settings
- Outpatient Settings
Breakup by Application:
- COPD
- Cystic Fibrosis
- Asthma
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Briggs Medical Service Company, Ca-Mi SRL, Besco Medical, Flyp Nebulizers, DeVilbiss Healthcare International, Omron Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., Feellife Health Inc., Invacare Corporation, Pari Medical Ltd., Philips Respironics, Inc., Agilent Technologies, Inc., Medline Industries, Inc. and Graham Field (GF) Health Products, Inc., etc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2021 |
Historical Period |
2016-2021 |
Forecast Period |
2022-2027 |
Units |
US$ Billion |
Segment Coverage |
Product Type, Portability, End-User, Application, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Companies Covered |
Briggs Medical Service Company, Ca-Mi SRL, Besco Medical, Flyp Nebulizers, DeVilbiss Healthcare International, Omron Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., Feellife Health Inc., Invacare Corporation, Pari Medical Ltd., Philips Respironics, Inc., Agilent Technologies, Inc., Medline Industries, Inc. and Graham Field (GF) Health Products, Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global nebulizers market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global nebulizers industry?
- What has been the impact of COVID-19 on the global nebulizers market?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the portability?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the global nebulizers industry?
- What are the key driving factors and challenges in the global nebulizers industry?
- What is the structure of the global nebulizers industry and who are the key players?
- What is the degree of competition in the global nebulizers industry?
- What are the profit margins in the nebulizers industry?